Anti-oxidants, controversies and perspectives: How can the failure of clinical studies using anti-oxidants be explained?;Anti-oxydants, controverses et perspectives: Comment expliquer léchec des études cliniques utilisant des anti-oxydants

Journal de la Societe de Biologie

Volumn 203, Issue 3, 2009, Pages 271-280

  Edeas, Marvin ^a  

^a International Antioxidants Task Force   (France)

Author keywords

Anti oxidants; glycation; mitochondria; nutrigenomics; oxidative stress

Indexed keywords

ANTIOXIDANT; REACTIVE OXYGEN METABOLITE;

ANIMAL; BIOAVAILABILITY; BIOLOGICAL MODEL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FORECASTING; GLYCOSYLATION; HUMAN; METHODOLOGY; MITOCHONDRION; NUTRIGENOMICS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PHYSIOLOGY; REVIEW; TREATMENT FAILURE;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FORECASTING; GLYCOSYLATION; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NUTRIGENOMICS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RESEARCH DESIGN; TREATMENT FAILURE;

EID: 77951209708     PISSN: 12950661     EISSN: None     Source Type: Journal    
DOI: 10.1051/jbio:2009031     Document Type: Article

References (46)

1. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., Hartman A.M., Palmgren J., Freedman L.S., Haapakoski J., Barrett M.J., Pietinen P., Malila N., Tala E., Liippo K., Salomaa E.R., Tangrea J.A., Teppo L., Askin F.B., Taskinen E., Erozan Y., Greenwald P., Huttunen J.K., Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, betacarotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst, 1996, 6, 88, 1560-1570.
2. Bahat-Stroomza M., Gilgun-Sherki Y., Offen D., Panet H., Saada A., Krool-Galron N., Barzilai A., Atlas D., Melamed E., A novel thiol Anti-oxidants that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. Eur J Neurosci, 2005, 21, 637-646.
3. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud C., Systematic review: primary and secondary prevention of gastrointestinal cancers with Anti-oxidants supplements. Aliment Pharmacol Ther, 2008, 28, 689-703.
4. Bjelakovic G., Nikolova D., Gluud L.L., Simonetti R.G., Gluud C., Anti-oxidants supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev, 2008, 2, CD007176.
5. Bjelakovic G., Nagorni A., Nikolova D., Simonetti R.G., Bjelakovic M., Gluud C., Meta-analysis: Anti-oxidants supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther, 2006, 24, 281-291.
6. Bjelakovic G., Nikolova D., Simonetti R.G., Gluud C., Anti-oxidants supplements for prevention of gastrointestinal cancers: a systematic review and metaanalysis. The Lancet, 2004, 364, 1219-1228.
7. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., Vidal H., Rieusset J., Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest, 2008, 118, 789-800.
8. Borel P., Moussa M., Reboul E., Lyan B., Defoort C., Vincent-Baudry S., Maillot M., Gastaldi M., Darmon M., Portugal H., Planells R., Lairon D., Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr, 2007, 137, 2653-2659.
9. Bors W., Heller W., Michel C., Satan M., Flavonoids as Anti-oxidantss: determination of radical-scavengingefficiencies. Methods in Enzymology, 1990, 186, 343.
10. Bugger H., Abel E.D., Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond), 2008, 114, 195-210.
11. Caillavet F., Darmon N., Contraintes budgétaires et choix alimentaires. Pauvreté des ménages, pauvreté de l'alimentation ? Inra Sciences Sociales, 2005, 3-4.
12. Castelao J.E., Gago-Dominguez M., Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses, 2008, 71, 39-44.
13. Cerellio A., New insights on oxidative stress and diabetic complications may lead to a "causal" Anti-oxidants therapy. Diabetes Care, 2003, 26, 1589-1596.
14. Ceriello A., Motz E., Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease ? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol, 2004, 24, 816-823.
15. Darmon N., Darmon M., Fruits et légumes : en a-t-on pour son argent ? Equation Nutrition (APRIFEL), 2005, 46.
16. Darmon N., équilibre alimentaire : une question d'argent ? Diab́etologie et facteurs de risque, 2006, 97, 7-11.
17. Du Z.X., Zhang H.Y., Meng X., Guan Y., Wang H.Q., Role of oxidative stress and intracellular glutathione in the sensitivity to apoptosis induced by proteasome inhibitor in thyroid cancer cells. BMC Cancer, 2009, 9, 56.
18. Edeas M.A. et al., Mitochondrial generation of reactive oxygen species (ROS) and its targeting by Antioxidantss. Agro Food Industry Hi-Tech, 2007, 18, 17-22.
19. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I., Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest, 2004, 114, 1752-1761.
20. Heinonen O., Albanes D., The effect of vitamin E and β-caroten on he incidence of lung cancer and other cancers in male smokers. N Engl J Med, 1996, 334, 1150-1155.
21. Hercberg S., The SU.VI.MAX study, a randomized, placebo-controlled trial on the effects of Antioxidants, vitamins and minerals on health. Annales Pharmaceutiques Fraņcaises, 2006, 64, 397-401.
22. Hudson B.I., Wendt T., Bucciarelli L.G., Rong L.L., Naka Y., Yan S.F., Schmidt A.M., Diabetic vascular disease : it's all the RAGE. Antiox Rep Signal, 2005, 7, 1588-1600.
23. Hunt J.V., Dean R.T., Wolff S.P., Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidative as the cause of protein damage in the expérimental glycation model of diabetes mellitus ang ageing. Biochem J, 1988, 256, 205-212.
24. Johansen J.S., Harris A.K., Rychly D.J., Ergul A., Oxidative stress and the use of Anti-oxidantss in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol, 2005, 4, 5.
25. Kinsky N., Anti-oxydants function of carotenoides. Free Rad Biol Med, 1989, 7, 617.
26. Loeb L.A., Wallace D.C., Martin G.M., The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci U S A, 2005, 102, 18769-18770.
27. Lorenz M., Jochmann N., von Krosigk A., Martus P., Baumann G., Stangl K., Stangl V., Addition of milk prevents vascular protective effects of tea. Eur Heart J, 2007, 28, 219-223.
28. Maritim A.C., Sanders R.A., Watkins J.B., 3rd. Diabetes, oxidative stress, and anti-oxidants: a review. J Biochem Mol Toxicol, 2003, 17, 24-38.
29. Martínez J.A., Mitochondrial oxidative stress and inflammation: a slalom to obesity and insulin resistance. J Physiol Biochem 2006, 62, 303-306.
30. McCord J.M., Edeas M.A., SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother, 2005, 59, 139-142.
31. Mehta J.L., Rasouli N., Sinha A.K., Molavi B., Oxidative stress in diabetes: A mechanistic overview of its effects on atherogenesis and myocardial dysfunction. Int J Biochem Cell Biol, 2006, 38, 794-803.
32. Miller E.R. 3rd, Pastor-Barriuso R. et al., Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann Intern Med, 2004, 10.
33. Niedowicz D.M., Daleke D.L., The role of oxidative stress in diabetic complications. Cell Biochem Biophys, 2005, 43, 289-330.
34. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., Keogh J.P., Meyskens F.L. Jr, Valanis B., Williams J.H. Jr, Barnhart S., Cherniack M.G., Brodkin C.A., Hammar S., Risk factors for lung cancer and for intervention effects in CARET, the beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst, 1996, 88, 1550-1559.
35. Packer L., Protective role of vitamin E in biological systems. Am J Clin Nutr, 1991, 53, 1050S.
36. Peterszegi G., Molinari J., Ravelojaono V., Robert L., Effect of advanced glycation end-products on cell proliferation and cell death. Pathologie Biologie, 2006, 54, 396-404.
37. Riso P., Martini D., Visioli F., Martinetti A., Porrini M., Effect of broccoli intake on markers related to oxidative stress and cancer risk in healthy smokers and nonsmokers. Nutr Cancer, 2009, 61, 232-237.
38. Robert L., An original approach to aging: an appreciation of Fritz Verzar contribution in the light of the last 50 years of gerontological facts and thinking. Gerontology, 2006, 52, 268-274.
39. Rosca M.G. et al., Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol, 2005, 289, F420-30.
40. Sies H., Oxidative stress: from basics research to clinical application. Am J Med, 1991, 90, 31S-38S.
41. Siems W., Wiswedel I., Salerno C., Beta-carotene breakdown products may impair mitochondrial functions- potential side effects of high-dose beta-carotene supplementation. J Nutr Biochem, 2005, 16, 385-397.
42. Trinei M., Giorgio M., Cicalese A., Ventura A., Migliaccio E., Milia E., Padura I.M., Raker V.A., Maccarana M., Petronilli V., Minucci S., Bernardi P., Lanfrancone L., Pelicci P.G., A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidationdamaged DNA and oxidative stress-induced apoptosis. Oncogene, 2002, 21, 3872-3878.
43. Van Raamsdonk J.M., Hekimi S., Deletion of the mitochondrial superoxide sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet, 2009, 5, e1000361.
44. Vauzour D., Ravaioli G., Vafeiadou K., Rodriguez-Mateos A., Angeloni C., Spencer J.P., Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. Arch Biochem Biophys, 2008, 476, 145-51.
45. Wiernsperger N.F., Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab, 2003, 29, 579-585.
46. Zelko I.N., Mariani T.J., Folz R.J., Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Rad Biol Med, 2002, 33, 337.